Tarsus Pharmaceuticals (TARS) PT Raised to $45 as Jefferies Sees Possibility of First Line Therapy
Go back to Tarsus Pharmaceuticals (TARS) PT Raised to $45 as Jefferies Sees Possibility of First Line Therapy| (NASDAQ: TARS) | Delayed: 68.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.88 | 52 Week High | $ | |||
| Open | $68.88 | 52 Week Low | $ | |||
| Day High | $68.88 | P/E | N/A | |||
| Day Low | $68.88 | EPS | $ | |||
| Volume | 14 | |||||
